OrganOx
United KingdomOrganOx is a healthcare company, headquartered in UK.
Entry
2022
Hold
3yr
Exit
2025
Est. EV
–
Who owns OrganOx?
OrganOx was owned by Lauxera Capital Partners through Lauxera Growth I (2022 vintage) from 2022 to 2025, exited via Trade Sale. Across its history, OrganOx has been through 4 private equity ownership periods, detailed in the timeline below.
Buyer identity available on Pro.
Hand-verified · updated 2026-04-21
Most recent investor
Lauxera Capital PartnersLauxera Growth I · 2022 · Growth
4 ownership periods · full history below
Key facts
HQUK
SectorHealthcare
Key takeaways
- ·Fully exited in 2025.
- ·Average hold across 4 realized cycles: 6 years.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Exited
Last exited in 2025 to .
Co-invest · 4 holders · 2011 · 2025
Amadeus Capital PartnersExited 2025
2011 · 2025 · Amadeus IV Digital Prosperity Fund · 2013 · Growth
Trade Sale · to
MOIC
–
MOIC
–
More from Lauxera Growth I
Other portfolio companies in the same fund.
Sweden
France
Germany
DenmarkMore PE-backed in Healthcare
Comparable healthcare deals from other GPs.
USData refreshed weekly · Sourced from public filings